English | Español

University of California Los Angeles
+ Technology/Innovation
Kim Sunderland | May 17, 2016

PICI dream teams rush development of sophisticated immune therapies
+ Technology/Innovation
Jamie Barrand | Dec 16, 2015

Bristol-Myers Squibb, UCLA team up for cancer research

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes